Devyser is a biotechnology startup that has the slogan "A new level of certainty." The company specializes in diagnostic kits for complex DNA testing within oncology, hereditary diseases, and transplantation. Founded in 2004, Devyser's products are used to guide targeted cancer therapies, enable rapid prenatal diagnostics, and aid in post-transplant follow-up. Their guiding principle revolves around the development of products that are ideal for routine diagnostics - making the technology simple, reproducible, and less prone to user-generated errors.
Devyser has gained recognition and trust from customers worldwide, with routine diagnostic laboratories in over 60 countries utilizing their products. The company aims to provide a new level of certainty in the field of genetic testing and diagnostics, and its focus on precision and reliability is evident in its widespread adoption within the healthcare industry.
There is no investment information
No recent news or press coverage available for Devyser.